Funding of translational projects for therapies with gene- and cell-based products and associated diagnostics
The aim of this funding program is to support the translation of research results in the field of GCT and thus contribute to the implementation of a National Strategy for Gene- and Cell-based Therapies in Germany.
The DLR Projekträger (Project Managment Agency at German Aerospace Center) has announced the ➚ funding opportunities (DE) on 15 July 2024.
For further information, please refer to the ➚ announcement (DE) and the publication ↓ National Strategy for Gene- and Cell-based Therapies in Germany from the BIH.
Apply NOW!: ➚ GeneNovate Investors' Day 2025
At GeneNovate Investors' Day, we bring together ambitious start-ups with investors, industry representatives, scientists, patient organisation advocates and experts from politics and regulation. Let's shape the future of medicine together!
Application Deadline: 16 December 2024
Join the ➚ GeneNovate Program 2025
GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT).
Participating sites: Berlin (Deadline: 6.1.25), Dresden/Leipzig (6.1.25), Heidelberg (2.12.24), Mainz (10.12.24), Munich (1.12.2024)